Jan W Garber

Title: Jan W Garber: Innovator in Hemoglobin Therapy

Introduction

Jan W Garber is a notable inventor based in Barrington, IL (US), recognized for her contributions to medical innovations, particularly in the field of hemoglobin therapy. With a total of 8 patents, her work has significantly impacted the treatment of patients undergoing hemodialysis.

Latest Patents

One of her latest patents focuses on hemoglobin therapy in hemodialysis. In this innovative approach, low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients. This method aims to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Furthermore, when implemented prophylactically, this therapy partially obviates the need for further interventions to control circulatory system instability.

Career Highlights

Throughout her career, Jan has worked with prominent companies such as Baxter Travenol Laboratories, Inc. and Baxter International Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in medical therapies.

Collaborations

Jan has collaborated with esteemed colleagues, including De Wayne Davisson and Henry M Gajewski. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Jan W Garber's work in hemoglobin therapy represents a significant advancement in medical treatment for hemodialysis patients. Her innovative approach and dedication to improving patient care continue to inspire future developments in the field.